Urinary thromboxane metabolite (TXA-M) concentrations of pre-CABG, post-CABG 6 hours and post-CABG 24 hours in control patients and patients who died, patients with stroke, patients with MI and patients with repeat revascularisation
| Number | Pre-CABG | P values | Post-CABG 6 hours | P values | Post-CABG 24 hours | P values | |
| Patients with MACCE | |||||||
| Control patients | 168 | 5076 (3398~7593) | – | 25 681 (17612~35 005) | – | 8849 (5530~12 552) | – |
| Death | 16 | 4879 (1680~9325) | 0.596 | 26 689 (20423~26689) | 0.441 | 11 993 (8614~23 384) | 0.039 |
| Stroke | 26 | 4583 (2713~5875) | 0.197 | 26 156 (13426~36 372) | 0.847 | 11 138 (8764~15 021) | 0.016 |
| MI | 2 | 2550 (−) | 0.075 | 17 029 (−) | 0.225 | 13 585 (−) | 0.444 |
| Revascularisation | 12 | 3384 (2554~6765) | 0.931 | 21 502 (12965~32 440) | 0.335 | 8059 (6577~13 642) | 0.931 |
Values are median (IQR).
CABG, coronary artery bypass graft; MI, myocardial infarction; MACCE, major adverse cardiac and cerebrovascular events.